Adage Capital Partners’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-41,900
| Closed | -$1.76M | – | 934 |
|
|
2024
Q3 | $1.76M | Sell |
41,900
-120,000
| -74% | -$5.04M | ﹤0.01% | 788 |
|
|
2024
Q2 | $5.89M | Sell |
161,900
-9,745
| -6% | -$355K | 0.01% | 690 |
|
|
2024
Q1 | $8.74M | Buy |
171,645
+36,064
| +27% | +$1.84M | 0.02% | 621 |
|
|
2023
Q4 | $2.63M | Buy |
135,581
+58,081
| +75% | +$1.13M | 0.01% | 730 |
|
|
2023
Q3 | $1.22M | Buy |
+77,500
| New | +$1.22M | ﹤0.01% | 758 |
|
|
2018
Q2 | – | Sell |
-25,000
| Closed | -$7.04M | – | 775 |
|
|
2018
Q1 | $7.04M | Buy |
25,000
+12,500
| +100% | +$3.52M | 0.02% | 608 |
|
|
2017
Q4 | $2.94M | Hold |
12,500
| – | – | 0.01% | 652 |
|
|
2017
Q3 | $3.55M | Buy |
+12,500
| New | +$3.55M | 0.01% | 645 |
|